Cortechs.ai | Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Increased Physician Access to Volumetric MRI Processing with Additional Scanner Options, Including Open MRIs

(SAN DIEGO) – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners are compatible with NeuroQuant®, the foremost medical device software for volumetric MRI processing. Cortechs.ai and Hitachi worked together to validate the 1.2T, 1.5T and 3.0T Hitachi MRI scanners, ensuring accurate and consistent brain segmentation results for Hitachi MRI customers.

This capability provides neuroradiologists in hospitals, clinics, imaging and research centers worldwide with expanded MRI scanner options when using Cortechs.ai automated brain image analysis software solutions in the assessment of neurodegeneration disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis, as well as, brain volume changes caused by brain trauma.

Cortechs.ai’ fast, accurate, reproducible, and proven quantitative imaging solution is the first FDA cleared and CE marked software that provides radiologists and neurologists with quantifiable, volumetric data to help in the assessment of brain atrophy and lesion evolution.

“This Hitachi scanner validation marks the first time that NeuroQuant products can be used with open MRI scanners, helping to accommodate a broader patient demographic for neurodegenerative evaluations,” said Guri Stark, Cortechs.ai’ CEO. “We are excited to include Hitachi 1.2T, 1.5T and 3.0T MRI scanners as options for NeuroQuant analysis, thereby strengthening our goal of providing a vendor neutral product, allowing physicians and clinicians more freedom in MRI scanner choices.”

“We are always looking to provide our customers with enhanced and expanded imaging capabilities,” said Sheldon Schaffer, Vice President and General Manager, MR/CT, Hitachi Healthcare Americas. “With NeuroQuant products now validated and compatible with Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners, healthcare providers have access to exceptional automated brain volume imaging technology, allowing them to deliver better patient care in Hitachi’s unique patient-centric environment.”

ABOUT CORTECHS LABS
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

ABOUT HITACHI HEALTHCARE AMERICAS
Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.

ABOUT HITACHI, LTD.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com

More Resources

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network

07/08/2026

The Hidden Tax on Every Head CT You Read

Why automated, consistent alignment, and the reformats it makes possible, may be the most overlooked upgrade in neuroimaging.

06/23/2026

Helping Our Clients Share Their Success Stories

Learn how Cortechs helps clients share clinical achievements, workflow improvements, and innovation through case studies, testimonials, webinars, and more.

06/15/2026

Alzheimer’s Awareness Month: Bringing Clarity to the Alzheimer’s Care Continuum Through Quantitative Imaging

Explore how quantitative imaging is helping clinicians assess, diagnose, and monitor Alzheimer’s disease and related dementias with greater clarity.

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.
Scroll to Top